-Antisecretory therapy, when oral administration is not possible for treatment of the following conditions: gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux;
-treatment of NSAID therapy associated stomach ulcer;
-prevention of NSAID therapy associated gastric and duodenal ulcers in high-risk patients.
Post-therapeutic endoscopy rebleeding prevention in acute stomach or duodenum bleeding
Children from 1 to 18 years old
Antisecretory therapy, when oral administration is not possible for gastroesophageal reflux disease (GERD) treatment in patients with esophagitis and/or severe symptoms of reflux.
Dosage form:
Lyophilized powder for intravenous solution preparation
Pharmacotherapeutic group:
Anti-ulcer drugs and gastroesophageal reflux disease (GERD) treatment drugs
INN:
Esomeprazole
Производство:
REB-PHARMA
